oa Journal of Endocrinology, Metabolism and Diabetes in South Africa - ActosTM maintains effective long-term glucose control in type 2 diabetes : advertorial
|Article Title||ActosTM maintains effective long-term glucose control in type 2 diabetes : advertorial|
|© Publisher:||Medpharm Publications|
|Journal||Journal of Endocrinology, Metabolism and Diabetes in South Africa|
|Publication Date||Jul 2005|
Extracted from text ... A review of 4-year data of clinic patients with type 2 diabetes who had continuously received ActosTM (pioglitazone) 30 or 45 mg/day and no other thiazolinidiones shows that treatment with ActosTM was associated with sustained and progressive reduction of hypoglycaemia over that treatment period.1 In addition, after combination with ActosTM, the dose of other concomitant antidiabetic medications, including sulphonylureas, metformin and insulin, could be reduced during the first year of treatment and maintained for the entire 4 years. In many type 2 diabetics treated with other oral antihypoglycaemic agents, glycaemic control often deteriorates as a consequence of progressive loss ..
Article metrics loading...